Comorbid conditions in patients with rheumatic diseases: An update

Current Opinion in Rheumatology

Volumn 16, Issue 2, 2004, Pages 109-113

  Wasko, Mary Chester M ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Cardiovascular disease; Comorbid conditions; Infection; Malignancy; Rheumatic diseases

Indexed keywords

ADALIMUMAB; ANTIRHEUMATIC AGENT; CORTICOSTEROID; ETANERCEPT; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PROTEIN INHIBITOR; TUMOR NECROSIS FACTOR;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMORBIDITY; DRUG EFFECT; HUMAN; INFECTION; INFECTION RISK; LYMPHOMA; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS;

CARDIOVASCULAR DISEASES; COMORBIDITY; HUMANS; INFECTION; NEOPLASMS; RHEUMATIC DISEASES;

EID: 1442348161     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-200403000-00006     Document Type: Review

References (21)

1. Doran MF, Crowson CS, Pond GR, et al.: Frequency of infection in patients with rheumatoid arthritis compare with controls. Arthritis Rheum 2002, 46:2287-2293.
2. Doran MF, Crowson CS, Pond GR, et al.: Predictors of infection in rheumatoid arthritis. Arthritis Rheum 2002, 46:2294-2300.
3. Del Rincon I, Williams K, Stern MP, et al.: Associations between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum 2003, 45:1833-1840.
4. Van Doornum S, McColl G, Jenkins A, et al.: Screening for atherosclerosis in patients with rheumatoid arthritis. Arthritis Rheum 2003, 48:72-80.
5. Watson DJ, Rhodes T, Guess HA: All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK general practice research database. J Rheumatol 2003, 30:1196-1202.
6. Wolfe F, Freundlich B, Straus W: Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J Rheumatol 2003, 30:36-40.
7. Solomon DH, Karlson EW, Rimm EB, et al.: Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003, 107:1303-1307.
8. Minden K, Niewerth M, Listing J, et al.: Long-term outcome in patients with juvenile idiopathic arthritis. Arthritis Rheum 2002, 46:2392-2401.
9. Gordon C: Long-term complications of systemic lupus erythematosus. Rheumatology 2002, 41:1095-1100.
10. Al-Herz A, Ensworth S, Shojania K, et al.: Cardiovascular risk factor screening in systemic lupus erythematosus. J Rheumatol 2003, 30:493-496.
11. Abu-Shakra M, Ehrenfeld M, Shoenfeld Y: Systemic lupus erythematosus and cancer: associated or not? Lupus 2002, 11:137-144.
12. Bematsky S, Boivin J-F, Joseph L, et al.: Prevalence of factors influencing cancer risk in women with lupus: social habits, reproductive issues, and obesity. J Rheum 2002, 29:2551-2554.
13. Food and Drug Administration: US Department of Health and Human Services. Arthritis Advisory Board Meeting, March 4, 2003. Available at: http://www.fda.gov/ohrms/dockets/ac/acmenu.htm [accessed December 12, 2003].
14. Cush JJ, Kavanaugh A: American College of Rheumatology: HOTLINE. March 3, 2003. Available at: http://www.rheumatology.org/publications/hotline/ 0803chf.asp [accessed December 12, 2003].
15. Baecklund E, Ekbom A, Sparen P, et al.: Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study. BMJ 1998, 517:180-181.
16. Wolfe F: Inflammatory activity, but not methotrexate or prednisone use, predicts non-Hodgkin's lymphoma in rheumatoid arthritis: a 25 year study of 1767 RA patients. Arthritis Rheum 1998, 41:S188.
17. Gridley G, McLaughlin JK, Ekbom A, et al.: Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 1993, 85:307-311.
18. Mellemkjaer L, Linet M, Gridley G, et al.: Rheumatoid arthritis and cancer risk. Eur J Cancer 1996, 32A:1753-1757.
19. Isomaki HA, Hakulinen T, Joutsenlahti U: Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis. J Chronic Dis 1978, 31:691-696.
20. Matteson E, Hickey AR, Maguire L, et al.: Occurrence of neoplasia inpatients with rheumatoid arthritis enrolled in a DMARD Registry. Rheumatoid Arthritis Azathioprine Registry Steering Committee. J Rheumatol 1991, 18:809-814.
21. Ekstrom K, Hjalgrim H, Brandt L, et al.: Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first degree relatives. Arthritis Rheum 2003, 48:963-970.